Daly James M
SEC CIK 1560782 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | Dir | 3,390 | — | — | 4 | 2026-01-15 | 2026-07-15 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 3,081 | — | $13.59M | 8 | 2023-06-15 | 2026-06-17 |
| ACAD | ACADIA PHARMACEUTICALS INC | Dir | 12.1K | — | $671.1K | 5 | 2021-06-22 | 2026-05-29 |
| HALO | HALOZYME THERAPEUTICS, INC. | Dir | 30.5K | — | $874.5K | 3 | 2022-05-05 | 2023-08-11 |
Most active insiders at CYTK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Blum Robert I | Pres, CEO, Dir | — | $17.08M |
| 2 | Callos Andrew | EVP, Chief Commercial Off | — | $16.02M |
| 3 | Lee Sung | EVP, CFO | — | $5.70M |
| 4 | Malik Fady Ibraham | EVP Research, Development | — | $4.65M |
| 5 | Kaye Edward M. MD | Dir | — | $3.21M |
| 6 | HENDERSON JOHN T | Dir | — | $2.08M |
| 7 | WIERENGA WENDELL | Dir | — | $1.88M |
| 8 | PARSHALL B LYNNE | Dir | — | $1.36M |
| 9 | Landry Robert E | Dir | — | $146.8K |
| 10 | Harrington Robert Arthur | Dir | — | $143.6K |
| 13 | Daly James M | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 16:28 | 2026-07-15 | CYTK | CYTOKINETICS INC | Daly James M | Dir | A - Grant | $82.62 | +151 | 3,390 | +5% | +$12.5K | |
| D | 2026-06-18 16:16 | 2026-06-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | A - Grant | $0.00 | +454 | 3,081 | +17% | $0 |
| D | 2026-06-01 18:00 | 2026-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Dir | M - OptEx | — | +8,107 | 12.1K | +201% | — |
| D | 2026-05-27 19:14 | 2026-05-27 | CYTK | CYTOKINETICS INC | Daly James M | Dir | A - Grant | $0.00 | +2,851 | 3,239 | +735% | $0 |
| 2026-04-15 18:32 | 2026-04-15 | CYTK | CYTOKINETICS INC | Daly James M | Dir | A - Grant | $65.37 | +191 | 388 | +97% | +$12.5K | |
| 2026-01-20 | 2026-01-15 | CYTK | CYTOKINETICS INC | Daly James M | Dir | A - Grant | $63.44 | +197 | 197 | New | +$12.5K | |
| 2025-11-12 | 2025-11-10 | ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Dir | S - Sale | $22.37 | -30.0K | 4,041 | -88% | -$671.1K | |
| D | 2025-06-24 | 2025-06-20 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | A - Grant | $0.00 | +715 | 2,627 | +37% | $0 |
| D | 2025-06-02 | 2025-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Dir | M - OptEx | — | +9,387 | 34.0K | +38% | — |
| DM | 2025-02-28 | 2025-02-27 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | S - Sale+OE | $347.45 | -15.5K | 17.0K | -48% | -$5.38M |
| DM | 2025-02-28 | 2025-02-27 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | M - OptEx | $82.90 | +15.5K | 11.4K | New | +$1.28M |
| D | 2024-06-27 | 2024-06-25 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | A - Grant | $0.00 | +714 | 1,912 | +60% | $0 |
| D | 2024-05-31 | 2024-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Dir | M - OptEx | — | +6,652 | 24.7K | +37% | — |
| DM | 2024-04-03 | 2024-04-01+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | M - OptEx | $102.23 | +32.5K | 22.8K | New | +$3.32M |
| DM | 2024-04-03 | 2024-04-01+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | S - Sale+OE | $252.97 | -32.5K | 1,398 | -96% | -$8.22M |
| M | 2023-08-15 | 2023-08-11+ | HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Dir | S - Sale | $43.73 | -20.0K | 30.5K | -40% | -$874.5K |
| 2023-06-20 | 2023-06-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Daly James M | Dir | A - Grant | $0.00 | +1,198 | 1,198 | New | $0 | |
| DM | 2023-06-05 | 2021-06-22+ | ACAD | ACADIA PHARMACEUTICALS INC | Daly James M | Dir | M - OptEx | — | +18.0K | 9,450 | New | — |
| D | 2023-05-09 | 2023-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Dir | A - Grant | $0.00 | +8,065 | 40.5K | +25% | $0 |
| 2022-05-06 | 2022-05-05 | HALO | HALOZYME THERAPEUTICS, INC. | Daly James M | Dir | A - Grant | $0.00 | +6,206 | 32.4K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations